project id: TCGA-CESC; case submitter id: TCGA-VS-A8EL; source center: 23; state: released; a260 a280 ratio: 2.02; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.62; rna integrity number: 7.0; age at index: 38; days to birth: -14162; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1971; age at diagnosis: 14162; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic t: T2b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1992.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1589; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-VS-A8EL-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 40.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;